FDA Drug recall D-1261-2014
Potassium Chloride for Inj
- FDA Drug
- Class II
- terminated
- Published 2014-04-30
On 2014-04-30 the FDA classified a Class II recall of Potassium Chloride for Inj by Hospira, citing presence of Particulate; red and black particulate within the solution and embedded within the plastic vial identified as iron oxide.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1261-2014 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2014-03-27 |
| Published | 2014-04-30 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Hospira |
| Distribution | US |
Product
Potassium Chloride for Inj. Concentrate, USP, 40 mEq (2 mEq/mL), 20 mL Single-dose Fliptop Vial, For IV use, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA
Reason
Presence of Particulate; red and black particulate within the solution and embedded within the plastic vial identified as iron oxide
Identifiers
| code_info | Lot 22-127-DK |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1261-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.